Johnson Investment Counsel Inc Organon & Co. Transaction History

Johnson Investment Counsel Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $3,832 - $5,490	231 Added 1.62%	14,475 $251,000
Q2 2023 Aug 10, 2023	SELL	$19.27 - $24.63 $2,216 - $2,832	-115 Reduced 0.8%	14,244 $296,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $14,865 - $22,263	-694 Reduced 4.61%	14,359 $337,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $16,923 - $20,770	-726 Reduced 4.6%	15,053 $420,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $4,797 - $7,021	-205 Reduced 1.28%	15,779 $369,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $12,252 - $15,054	-387 Reduced 2.36%	15,984 $539,000
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $9,287 - $12,004	-305 Reduced 1.83%	16,371 $572,000
Q4 2021 Feb 15, 2022	BUY	$28.67 - $37.13 $287,502 - $372,339	10,028 Added 150.84%	16,676 $508,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $53,337 - $66,397	-1,863 Reduced 21.89%	6,648 $218,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $242,137 - $323,418	8,511 New	8,511 $258,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.